Abstract
Shufan Ren
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges
10.1097/qad.0000000000000071 · 2014
10.1056/nejmra1615896
10.1056/nejmra1615896
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
10.1097/qad.0b013e3283112b77 · 2008
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
10.1016/s0140-6736(14)60604-8 · 2014
Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis
10.1016/j.eclinm.2022.101613 · 2022
Inflammation-related morbidity and mortality among HIV-positive adults: how extensive is it?
10.1097/qai.0000000000001554 · 2018
Mechanism of increased cancer risk in HIV
10.47672/ejhs.522 · 2020
Malignancies in people living with HIV
2022
Identification of unique transcriptomic signatures and key genes through RNA sequencing and integrated WGCNA and PPI network analysis in HIV infected lung cancer
2022
Molecular changes of lung malignancy in HIV infection
10.1038/s41598-018-31572-6 · 2018
Comprehensive RNA-seq reveals molecular changes in kidney malignancy among people living with HIV
10.1016/j.omtn.2022.06.002 · 2022
Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
10.1177/1758835921992987 · 2021
Risk of cancer in persons with AIDS in Italy, 1985-1998
10.1038/sj.bjc.6601017 · 2003
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003
10.7326/0003-4819-148-10-200805200-00005 · 2008
Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study
10.1186/s12885-018-4963-8 · 2018
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis
10.1097/00002030-200205240-00009 · 2002
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals
10.1097/qai.0b013e3181b327ca · 2009
Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States
10.1093/jnci/djy010 · 2018
Recent trends for colorectal cancer screening in HIV-infected patients
10.1007/s10620-009-0774-8 · 2010
Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention
10.1111/j.1572-0241.2005.50038.x · 2005
10.1016/j.cell.2019.03.030
10.1016/j.cell.2019.03.030
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
10.21147/j.issn.1000-9604.2021.03.02 · 2021
10.1038/s41586-019-0987-8
10.1038/s41586-019-0987-8
10.1021/acs.jproteome.6b00391
10.1021/acs.jproteome.6b00391
Phosphoproteome and Biological Evidence Revealed Abnormal Calcium Homeostasis In Keloid Fibroblasts And Induction Of Aberrant Platelet Aggregation
10.1021/acs.jproteome.0c00984 · 2021
Finding missing proteins from the epigenetically manipulated human cell with stringent quality criteria
10.1021/acs.jproteome.5b00480 · 2015
Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications
10.1002/jev2.12145 · 2021
10.1021/acs.jproteome.7b00352
10.1021/acs.jproteome.7b00352
10.1038/ng1180
10.1038/ng1180
10.1073/pnas.0506580102
10.1073/pnas.0506580102
10.1016/j.xinn.2021.100141
10.1016/j.xinn.2021.100141
10.3389/fgene.2019.00858
10.3389/fgene.2019.00858
Comparative transcriptional analysis identified characteristic genes and patterns in hiv-infected immunological non-responders
10.3389/fimmu.2022.807890 · 2022
Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders
10.1016/j.phymed.2022.154103 · 2022
Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment
10.1016/j.clim.2021.108773 · 2021
The SC cell line as an in vitro model of human monocytes
10.1002/jlb.1a1221-680r · 2022
Mechanism of interferon-stimulated gene induction in HIV-1-infected macrophages
10.1128/jvi.00744-17 · 2017
10.1093/nar/gky869
10.1093/nar/gky869
10.1016/j.cels.2015.12.004
10.1016/j.cels.2015.12.004
ISGylation in Innate antiviral immunity and pathogen defense responses: a review
10.3389/fcell.2021.788410 · 2021
10.1016/j.chom.2012.08.010
10.1016/j.chom.2012.08.010 · doi-reference
Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation
10.1073/pnas.1505690112 · doi-reference
Cell-associated HIV RNA: a dynamic biomarker of viral persistence
10.1186/1742-4690-10-41 · doi-reference
Antiviral responses in cancer: boosting antitumor immunity through activation of interferon pathway in the tumor microenvironment
10.3389/fimmu.2021.782852 · doi-reference
10.4049/jimmunol.1302972
10.4049/jimmunol.1302972 · doi-reference
10.1016/j.trecan.2022.09.003
10.1016/j.trecan.2022.09.003 · doi-reference
Thrombospondin 2/Toll-Like Receptor 4 axis contributes to HIF-1alpha-derived glycolysis in colorectal cancer
10.3389/fonc.2020.557730 · doi-reference
10.1038/nature09907
10.1038/nature09907 · doi-reference
Integrin beta5 enhances the malignancy of human colorectal cancer by increasing the TGF-beta signaling
10.1097/cad.0000000000001050 · doi-reference
MMP14 predicts a poor prognosis in patients with colorectal cancer
10.1016/j.humpath.2018.03.030 · doi-reference
10.1002/ijc.24682
10.1002/ijc.24682 · doi-reference
Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis
10.1016/j.jprot.2015.05.037 · doi-reference
Overexpression of alphavbeta6 integrin alters the colorectal cancer cell proteome in favor of elevated proliferation and a switching in cellular adhesion that increases invasion
10.1021/pr301099f · doi-reference
10.1016/j.critrevonc.2014.12.006
10.1016/j.critrevonc.2014.12.006 · doi-reference
10.1158/2159-8290.cd-21-1059
10.1158/2159-8290.cd-21-1059 · doi-reference
10.1126/science.aax2957
10.1126/science.aax2957 · doi-reference
10.1016/j.gde.2017.10.007
10.1016/j.gde.2017.10.007 · doi-reference
10.1021/acs.jproteome.9b00542
10.1021/acs.jproteome.9b00542 · doi-reference
10.1016/j.cell.2020.05.043
10.1016/j.cell.2020.05.043 · doi-reference
10.1038/s41467-018-03121-2
10.1038/s41467-018-03121-2 · doi-reference
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
10.1080/20013078.2018.1535750 · doi-reference
10.1073/pnas.1609057113
10.1073/pnas.1609057113 · doi-reference
10.1186/s12977-022-00601-8
10.1186/s12977-022-00601-8 · doi-reference
10.1038/nm.4156
10.1038/nm.4156 · doi-reference